Zenovel delivers specialized Dossier In-Licensing Services to support pharmaceutical and biotech companies in evaluating licensing opportunities with confidence.
The service covers comprehensive dossier evaluation, including CTD/eCTD review, clinical data assessment, CMC document review, and submission history checks. It also includes gap identification and risk analysis to detect regulatory deficiencies, assess compliance exposure, and determine market readiness.
For better decision-making, Zenovel offers strategic licensing support through product feasibility analysis, opportunity assessment, target market pathway planning, and partner evaluation. The process is further strengthened with submission support, dossier transfer, HA query coordination, and lifecycle continuity planning to ensure smooth integration after licensing.
This service helps organizations achieve faster licensing decisions, lower regulatory risks, better market expansion strategies, and seamless product integration across global markets